Cargando…
Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results
BACKGROUND: To evaluate the long-term efficacy and toxicity of radiation therapy in patients with Stage IE primary ocular adnexal mucosa-associated lymphoid tissue lymphoma. METHODS: We designed a retrospective analysis to evaluate 81 patients with ocular adnexal mucosa-associated lymphoid tissue ly...
Autores principales: | Niwa, Masanari, Ishikura, Satoshi, Tatekawa, Kotoha, Takama, Natsuko, Miyakawa, Akifumi, Kubota, Toshinobu, Kato, Eriko, Shibamoto, Yuta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993363/ https://www.ncbi.nlm.nih.gov/pubmed/32000814 http://dx.doi.org/10.1186/s13014-020-1477-8 |
Ejemplares similares
-
Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014) -
Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a narrative review
por: Chung, Hyun Uk, et al.
Publicado: (2021) -
Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
por: Mino, T, et al.
Publicado: (2014) -
The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
por: Fukutsu, Kanae, et al.
Publicado: (2018) -
Intracranial relapse as a solitary mass of ocular adnexal lymphoma of the mucosa-associated lymphoid tissue type
por: Kim, Jung-Ho, et al.
Publicado: (2018)